We've got 465 shorthands for vaccine »
Acronyms that contain the term vaccine
What does vaccine mean? This page is about the various possible meanings of the acronym, abbreviation, shorthand or slang term: vaccine.
Possible matching categories:
Term | Definition | Rating |
---|---|---|
OPV | Oral Polio Vaccine | |
IPV | Inactivated Polio Vaccine | |
PCV | Pneumococcal Conjugate Vaccine | |
VIS | Vaccine Information Statement | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
VFC | Vaccine For Children | |
VPD | Vaccine Preventable Diseases | |
VAPP | Vaccine Associated Paralytic Polio | |
VAFSTF | Vaccine Associated Feline Sarcoma Task Force | |
VVM | Vaccine Vial Monitor | |
IPV | Inactivated Poliomyelitis Vaccine | |
YF-VAX | Yellow Fever Vaccine | |
AAVP | African AIDS Vaccine Programme | |
TOPV | Trivalent oral polio vaccine | |
VAS | Vaccine Associated Sarcoma | |
NVX | North American Vaccine, Inc. | |
HIB | Hemophilus Influenzae type B (vaccine) | |
PAVE | Partnership For Aids Vaccine Evaluation | |
VAPS | Vaccine Associated Polio Society | |
YFV-17D | Yellow Fever Virus Vaccine | |
SAVE | Support the AIDS Vaccine Effort | |
VRR | Vaccine Reaction Register | |
SAVE | Supporting Alabama's Vaccine Efforts | |
VMS | Vaccine Management System | |
MKV | Measles, Killed Vaccine | |
FV | Fun Vaccine | |
V-HIV | Vaccine for Human Immunodeficiency Virus | |
KV | Kayzet Vaccine | |
VD | Vaccine Dependent | |
TDaP | TETANUS, DIPHTHERIA AND PERTUSSIS (VACCINE) | |
OPV | Oral Polio Vaccine | |
DTAP | Diphtheria, Tetanus toxoids, and Acellular Pertussis vaccine | |
BCG | Bacille Calmette-Guérin (Tuberculosis) Vaccine | |
VAX | Vaccine | |
HepA | Hepatitis A Vaccine | |
EVIN | Electronic Vaccine Intelligence Network | |
2VHPV | Bivalent HPV Vaccine | |
ROTA | Rotavirus Vaccine (replaced by RV1 and RV5) | |
SIRVA | Shoulder injury related to vaccine administration | |
COVID | Covert Objective Vaccine ID | |
AVN | Australian Vaccine Network | |
MOPV | Monovalent Oral Polio Vaccine | |
PRP-T | Polyribosylribitol Phosphate-Tetanus Conjugate (Hib) Vaccine | |
MMR | Measles, Mumps & Rubella Vaccine | |
PROVE | Parents Requesting Open Vaccine Education | |
BOPV | Bivalent oral polio vaccine | |
VAPP | Vaccine Associated Paralytic Poliomyelitis | |
ROTA | Rotavirus Vaccine (replaced by the terms RV1 and RV5) | |
VAP | Vaccine Action Program | |
IVAC | International Vaccine Access Center | |
MACP | Meningococcal A + C Polysaccharide vaccine | |
AI | An HIV-1 isolate used in HIV vaccine development, which belongs to clade B, the clade to which most HIV-1 found in America and Europe belongs. | |
TIV | Trivalent (Inact.) Influenza Vaccine | |
Ty21a | Oral Typhoid Vaccine (live) | |
WCV | Whole Cell Vaccine | |
VERP | Vaccine Error Reporting Program | |
SAVI | Savisars Accelerated Vaccine Initiative | |
NCVIA | National Childhood Vaccine Injury Act of 1986 | |
VAERS | Vaccine Adverse Event Reporting System | |
LVV | Live Virus Vaccine | |
MenACWY | meningococcal conjugate vaccine capsular polysaccharide of serogroup C, W135, and Y | |
IIV | Inactivated Influenza Vaccine (formerly called TIV) | |
DTaP | Diphtheria and tetanus toxoids and acellular pertussis vaccine, pediatric formulation (replaced DTP) | |
Td | Tetanus & diphtheria Vaccine [adult/adol.] | |
Tdap | Tetanus, diphtheria & acellular pertussis vaccine, (for adult/adol.) | |
CVDPV | Circulating vaccine derived polio virus | |
GVAP | Global Vaccine Action Plan | |
VIDS | Vaccine Induced Death Syndrome | |
VICP | Vaccine Injury Compensation Program | |
EVIN | Electronic Vaccine Intelligence Network | |
GVMM | Global Vaccine Market Model | |
VGTI | Vaccine and Gene Therapy Institute | |
VGTI | Vaccine and Gene Therapy Institute | |
VGTI | Vaccine and Gene Therapy Institute | |
NRRV | Non Replicating Rotavirus Vaccine | |
VERSE | Vaccine Economics Research for Sustainability and Equity | |
VERSE | Vaccine Economics Research for Sustainability and Equity | |
VERSE | Vaccine Economics Research for Sustainability and Equity | |
VIMS | Vaccine Information Management System | |
VIS | Vaccine Information Statements | |
OPV | Oral Polio Vaccine (no longer available) | |
PPV | Pneumococcal Polysaccharide Vaccine (23-valent) (replaced by the term PPSV23) | |
HVAD | HIV Vaccine Awareness Day | |
DCVRN | Developing Country Vaccine Regulators Network | |
CVPF | Cell and Vaccine Production Facility | |
ADVA | Asian Dengue Vaccine Advocacy | |
ADVA | Asian Dengue Vaccine Advocacy | |
7vPCV | seven valent pneumococcal conjugate vaccine | |
NHVA | New Hampshire Vaccine Association | |
NHVA | New Hampshire Vaccine Association | |
PEVA | Pharmacy Expanding Vaccine Access | |
PEVA | Pharmacy Expanding Vaccine Access | |
BQV | Black Quarter Vaccine | |
VBIR | Vaccine Based Immunotherapy Regimen | |
AVRC | Alabama Vaccine Research Clinic | |
IVS | Institute for Vaccine Safety | |
CVI | Clinical and Vaccine Immunology | |
MIRV | Merieux Inactivated Rabies Vaccine | |
VX | Vaccine for cat or dog | |
MMRV | Measles, Mumps, Rubella & Varicella Vaccine | |
MR | Measles-rubella Vaccine | |
PRV | Pentavalent Rotavirus Vaccine | |
CVR | Center for Vaccine Research | |
MCV | Measles Containing Vaccine | |
AVRS | AIDS Vaccine Research Subcommittee | |
SRVP | Self Reliance For Vaccine Production | |
HZV | Herpes zoster vaccine | |
TIV | Trivalent (Inactivated) Influenza Vaccine (replaced by the term IIV) | |
OPVO | Oral Polio Vaccine OPV | |
TTCV | Tetanus Toxoid Containing Vaccine | |
VIDO | Vaccine and Infectious Disease Organization | |
VIDO | Vaccine and Infectious Disease Organization | |
HTMV | High titre measles vaccine | |
NVEC | National Vaccine Evaluation Consortium | |
NVIC | National Vaccine Information Center | |
VCCM | Vaccine and Cold Chain Manager | |
VADE | Vaccine Associated Disease Enhancement | |
VADE | Vaccine Associated Disease Enhancement | |
SAAVI | South African AIDS Vaccine Initiative | |
SAAVI | South African AIDS Vaccine Initiative | |
VITT | Vaccine Induced Thrombotic Thrombocytopenia | |
DVC | DynPort Vaccine Company | |
SAVP | South African Vaccine Producers | |
CVD | Center for Vaccine Development | |
IVI | International Vaccine Institute | |
VRC | Vaccine Research Center | |
OCV | Oral Cholera Vaccine | |
VVM | Vaccine Vial Monitors | |
CVP | Connecticut Vaccine Program | |
OVG | Oxford Vaccine Group | |
NDV | Newcastle Disease Vaccine | |
VIG | Vaccine Immune Globulin | |
PPV-23 | pneumococcal polysaccharides vaccine, 23-valent | |
ZOS | Zoster (Shingles) Vaccine | |
EVAP | European Vaccine Action Plan | |
SRVP | Self Reliance in Vaccine Production | |
MenACWY-CRM | Meningococcal Conjugate Vaccine, Quadrivalent (Menveo®) | |
AVRL | AIDS Vaccine Research Laboratory | |
AVRL | AIDS Vaccine Research Laboratory | |
AVRL | AIDS Vaccine Research Laboratory | |
HSRV | Heat Stable Rotavirus Vaccine | |
HVTR | HIV Vaccine Translational Research | |
HVTR | HIV Vaccine Translational Research | |
ACVR | Annual Conference on Vaccine Research | |
ACVR | Annual Conference on Vaccine Research | |
ACVR | Annual Conference on Vaccine Research | |
JVAP | Joint Vaccine Acquisition Program | |
BOPV | Bivalent Oral Poliovirus Vaccine | |
NOVAC | Network Organization for Vaccine Awareness and Choice | |
LIV | Live Influenza Vaccine | |
LIV | Live Influenza Vaccine | |
VIE | Vaccine Injury Epidemic | |
VCCM | Vaccine Cold Chain Manager | |
VSDA | Vaccine Safety and Development Activity | |
VSDA | Vaccine Safety and Development Activity | |
VERS | Vaccine Event Reporting System | |
NVSI | National Vaccine Serum Institute | |
NVSI | National Vaccine Serum Institute | |
SAGV | Streptococcus Agalactiae Ghost Vaccine | |
PVW | Preteen Vaccine Week | |
VPAS | Vaccine Provider Agreement System | |
SCVD | Sealy Center for Vaccine Development | |
SCVD | Sealy Center for Vaccine Development | |
IVV | Influenza Virus Vaccine | |
IVV | Influenza Virus Vaccine | |
SIVE | Seasonal Influenza Vaccine Effectiveness | |
SIVE | Seasonal Influenza Vaccine Effectiveness | |
KAVI | Kenya AIDS Vaccine Initiative | |
KAVI | Keniase Aids Vaccine Initiative | |
SVP | Synthetic Vaccine Particle | |
SVP | Synthetic Vaccine Particles | |
AVEC | Anthrax Vaccine Expert Committee | |
VSD | Vaccine Safety Datalink | |
IPV | Inactivated Poliovirus Vaccine | |
GAVI | Global AIDS Vaccine Initiative | |
EVI | European Vaccine Initiative | |
HBV | Hepatitis B vaccine | |
EVM | Effective Vaccine Management | |
VBIR | Vaccine Based Immunotherapy Regimens | |
CAVD | Collaboration for AIDS Vaccine Discovery | |
AVAC | Adult Vaccine Access Coalition | |
VOMS | Vaccine Ordering and Management System | |
HPV | Human papillomavirus vaccine | |
Ty21a | Live Oral Typhoid Vaccine | |
CCVC | Colorado Coalition for Vaccine Choice | |
LVV | Live Varicella Vaccine | |
IVAC | International Vaccine Access Center | |
CVV | Candidate Vaccine Virus | |
VSN | Vaccine Safety Net | |
DCVRN | Developing Country Vaccine Regulator Network | |
DCVRN | Developing Countries Vaccine Regulatory Network | |
DCVRN | Developing Countries Vaccine Regulatory Network | |
DCVRN | Developing Countries Vaccine Regulators Network | |
DCVRN | Developing Countries Vaccine Regulators Network | |
CVIA | Center for Vaccine Innovation and Access | |
IVAC | International Vaccine Access Centre | |
IVAC | International Vaccine Access Centre | |
VICP | Vaccine Injuries Claim Program | |
MVIP | Malaria Vaccine Implementation Programme | |
MLV | Modified Limited Vaccine | |
TVRP | Therapeutic and Vaccine Research Program | |
TVRP | Therapeutic and Vaccine Research Program | |
BOPV | Bivalent Oral Poliomyelitis Vaccine | |
VERP | Vaccine Errors Reporting Program | |
CIV | Canine Influenza Vaccine | |
AVEC | Anthrax Vaccine Expert Committee | |
FIPV | Formaldehyde Inactivated Pertussis Vaccine | |
FIPV | Fractional Inactivated Poliomylitis Vaccine | |
SVBC | Saudi Vaccine Biomanufacturing Center | |
NVSI | National Vaccine and Serum Institute | |
NVSI | National Vaccine and Serum Institute | |
VDPS | Vaccine Damage Payment Scheme | |
VIC | Vaccine Immunotherapy Center | |
VIC | Vaccine and Immunotherapy Center | |
IPV | Immunizations Polio Vaccine | |
SLPV | Sabin Live Polio Vaccine | |
TOPV | Trivalent Oral Poliomyelitis Vaccine | |
CAVD | Computer Assisted Vaccine Design | |
CAVD | Computer Assisted Vaccine Design | |
VHIP | Vaccine Hesitancy Intervention Provider | |
SVAC | Southern Vaccine Advocacy Challenge | |
VSRR | Vaccine Status Reporting Regulation | |
VRAN | Vaccine Risk Awareness Network | |
VSQ | Vaccine Supply and Quality | |
MBV | Mixed Bacteria Vaccine | |
LVK | Leukemia Vaccine Killed | |
DRV | DNA Rabies Vaccine | |
DRV | DNA Rabies Vaccine | |
VVC | Vanderbilt Vaccine Center | |
VAF | Vaccine Associated Fibrosarcoma | |
OVRR | Office of Vaccine Research and Review | |
OVRR | Office of Vaccine Research and Review | |
PVRD | Poxvirus Vaccine Regimen Design | |
VOMS | Vaccine Ordering Management System | |
VOMS | Vaccine Ordering Management System | |
OPV | Oral Poliovirus Vaccine | |
OPV | Oral Poliomyelitis Vaccine | |
LVS | Live Vaccine Strain | |
PPSV | Pneumococcal Poly Saccharide Vaccine | |
VEC | Vaccine Education Center | |
VEC | Vaccine Education Center | |
VSQ | Vaccine Safety Quarterly | |
RIV | Recombinant Influenza Vaccine | |
RIV | Recombinant Influenza Vaccine | |
TBV | Transmission Blocking Vaccine | |
VEI | Vaccine Equity Initiative | |
VAR | Vaccine Administration Record | |
MVPE | Malaria Vaccine Pilot Evaluation | |
MVPE | Malaria Vaccine Programme Evaluation | |
VCN | Vaccine Confidence Network | |
SSV | State Supplied Vaccine | |
VOCP | Vaccine Outreach and Counseling Program | |
AVAP | Alaska Vaccine Assessment Program | |
AVAP | Alaska Vaccine Assessment Program | |
VAI | Vaccine Access Initiative | |
VITT | Vaccine Induced Thrombocytopenia and Thrombosis | |
VITT | Vaccine Induced Thrombosis and Thrombocytopenia | |
CVI | Cancer Vaccine Institute | |
CVI | Cancer Vaccine Institute | |
CVI | Cancer Vaccine Institute | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-InterVac | Vaccine and Infectious Disease Organization-International Vaccine Centre | |
VIDO-INTERVAC | Vaccine and Infectious Disease Organization – International Vaccine Centre | |
VIDO-INTERVAC | Vaccine and Infectious Disease Organization – International Vaccine Centre | |
VIDO-INTERVAC | Vaccine and Infectious Disease Organization – International Vaccine Centre | |
VIDO-INTERVAC | Vaccine and Infectious Disease Organization – International Vaccine Centre | |
VIDO-INTERVAC | Vaccine and Infectious Disease Organization – International Vaccine Centre | |
SAVI | Sars Accelerated Vaccine Initiative | |
NVPO | National Vaccine Program Office | |
IAVG | Inter-Agency Vaccine Group | |
IPV | Inactivated Polio Vaccine | |
NVICP | National Vaccine Injury Compensation Program | |
NVP | National Vaccine Program | |
AVEG | AIDS Vaccine Evaluation Group | |
NVC | National Vaccine Commission | |
VE | Vaccine Efficacy | |
VCTB | Vaccine Clinical Trials Branch | |
VEB (CBER) | Vaccine Evaluation Branch (CBER) | |
VSB (CBER) | Vaccine Safety Branch (CBER) | |
BVB | Bacterial Vaccine and Allergenic Products Branch | |
MPSV4 | quadrivalent meningococcal polysaccharide vaccine | |
VDPV | Vaccine-Derived Polio Virus | |
VDPV | Vaccine-Derived Polio Virus | |
VIS | Vaccine Information Statement | |
MMRV | Measles, Mumps & Rubella Vaccine | |
VAERS | Vaccine Adverse Event Reporting System | |
IIV | Inactivated Influenza Vaccine | |
LAIV | Live Attenuated Influenza Vaccine | |
NVI | Netherlands Vaccine Institute | |
QUIVER | WHO Advisory Committee on Quantitative Immunization and Vaccine Research | |
DPT | diphtheria, pertussis, tetanus vaccine | |
PPV | Pneumococcal Polysaccharide Vaccine | |
VAERS | Vaccine Adverse Events Reporting System | |
VS | Vaccine Serotype | |
VTN | Vaccine Trials Network | |
PCV13 | 13-valent pneumococcal conjugate vaccine | |
VPD | Vaccine Preventable Diseases | |
NVPO | National Vaccine Program Office | |
NVP | National Vaccine Program | |
PCV7 | 7-valent pneumococcal conjugate vaccine | |
SMPV | smallpox vaccine | |
IAVI | International AIDS Vaccine Initiative | |
NVSN | New Vaccine Surveillance Network | |
OPV | Oral Polio Vaccine | |
NVSN | New Vaccine Surveillance Network | |
AVA | Anthrax Vaccine Adsorbed | |
PCV | Pneumococcal Conjugate Vaccine | |
IIV4 | Inactivated Influenza Vaccine, Quadrivalent | |
IIV3 | Inactivated Influenza Vaccine, Trivalent | |
IPV | Inactivated Poliovirus Vaccine | |
HZV | Herpes Zoster (Shingles) Vaccine (formerly called ZOS) | |
HPV4 | Human Papillomavirus vaccine, quadrivalent (Gardasil®) | |
JE-MB | Inactivated, mouse brain-derived Japanese encephalitis vaccine (JE-Vax®) (no longer available) | |
JE-VC | Inactivated, Vero cell culture-derived Japanese encephalitis vaccine (Ixiaro®) | |
LAIV | Live, Attenuated Influenza Vaccine (Nasal Spray) | |
LAIV4 | Live, Attenuated Influenza Vaccine (Quadrivalent) | |
ccIIV3 | Cell-Culture Inactivated Influenza Vaccine, Trivalent (Flucelvax®) | |
DTP | Diphtheria and Tetanus toxoids and whole-cell pertussis vaccine, Pediatric formulation | |
DTwP | Diphtheria and Tetanus toxoids and whole-cell pertussis vaccine, Pediatric formulation | |
eIPV | Enhanced inactivated polio vaccine | |
HbOC | Haemophilus b Oligosaccharide Conjugate (Hib) Vaccine (no longer available) | |
HepB | Hepatitis B Vaccine | |
Hib-MenCY-TT | Hib-Meningococcal (Bivalent) Conjugate Vaccine (MenHibrix®) | |
HPV2 | Human Papillomavirus vaccine, bivalent (Cervarix®) | |
MCV4 | Meningococcal Conjugate Vaccine (Quadravalent) | |
MenACWY-CRM | Meningococcal Conjugate Vaccine, Quadrivalent (Menveo®) | |
MenACWY-D | Meningococcal Conjugate Vaccine, Quadrivalent (Menactra®) | |
MPSV4 | Meningococcal Polysaccharide Vaccine (Quadravalent) | |
or PCV | Pneumococcal Conjugate Vaccine (7-valent) (no longer available) | |
PCV7 | Pneumococcal Conjugate Vaccine (7-valent) (no longer available) | |
PCV13 | Pneumococcal Conjugate Vaccine (13-valent) (replaced PCV7) | |
PPV23 | Pneumococcal Polysaccharide Vaccine (23-valent) (replaced by the term PPSV23) | |
PPSV23 | Pneumococcal Polysaccharide Vaccine (23-valent) (formerly called PPV or PPV23) | |
PPV23 | Pneumococcal Polysaccharide Vaccine (23-valent) see PPSV23 | |
PRP | Polyribosylribitol Phosphate Polysaccharide (Hib) Vaccine (no longer available) | |
PRP-D | Polyribosylribitol Phosphate-Diphtheria Conjugate (Hib) Vaccine (no longer available) | |
PRP-OMP | Polyribosylribitol Phosphate-Outer Membrane Protein Conjugate (Hib) Vaccine | |
PRV | Pentavalent Rotavirus Vaccine (i.e., RotaTeq®) [replaced by "ROTA" subsequently "RVS"] | |
RIV3 | Recombinant Influenza Vaccine, Trivalent (Flublok®) | |
RRV-TV | Live, tetravalent rotavirus vaccine (RotaShield™) (no longer available) | |
RV1 | Rotavirus Vaccine, Monovalent | |
RV5 | Rotavirus Vaccine, Pentavalent | |
VAR | Varicella Vaccine | |
ViCPS | Vi Capsular Polysaccharide (Inact. Typhoid) Vaccine | |
YF | Yellow Fever vaccine | |
TIV | Trivalent Influenza Vaccine | |
VCTB (CBER) | Vaccine Clinical Trials Branch (CBER) | |
BVB (CBER) | Bacterial Vaccine and Allergenic Products Branch (CBER) | |
CMRV | Chloroform-Methanol Residue Vaccine | |
ILMV | Inactivated L. Monocytogenes Vaccine | |
LVID | Laboratory for Vaccine and Immunotherapy Delivery | |
BCG | Bacille Calmette-Guérin (Tuberculosis) Vaccine | |
DTaP | Diphtheria and tetanus toxoids and acellular pertussis vaccine, pediatric formulation (replaced DTP) | |
eIPV | Enhanced inactivated polio vaccine | |
HbOC | Haemophilus b Oligosaccharide Conjugate (Hib) Vaccine (no longer available) | |
HepA | Hepatitis A Vaccine | |
2vHPV | Bivalent HPV vaccine (Cervarix®) | |
4vHPV | Quadrivalent HPV vaccine (Gardasil®) | |
HZV | Herpes Zoster (Shingles) Vaccine (formerly called ZOS) | |
IIV | Inactivated Influenza Vaccine (formerly called TIV) | |
IIV4 | Inactivated Influenza Vaccine, Quadrivalent | |
JE-MB | Inactivated, mouse brain-derived Japanese encephalitis vaccine (JE-Vax®) (no longer available) | |
LAIV | Live Attenuated Influenza Vaccine | |
MenB | Serogroup B meningococcal vaccine | |
MenB-4C | Serogroup B meningococcal vaccine (Bexsero®) | |
MMRV | Measles, Mumps, Rubella & Varicella Vaccine | |
MR | Measles-rubella Vaccine | |
PCV7 (or PCV) | Pneumococcal Conjugate Vaccine (7-valent) (no longer available) | |
PPV23 (or PPV) | Pneumococcal Polysaccharide Vaccine (23-valent) (replaced by the term PPSV23) | |
PRP | Polyribosylribitol Phosphate Polysaccharide (Hib) Vaccine (no longer available) | |
PRP-OMP | Polyribosylribitol Phosphate-Outer Membrane Protein Conjugate (Hib) Vaccine | |
PRV | Pentavalent Rotavirus Vaccine (i.e., RotaTeq®) (replaced by the term ROTA, then by RV5) | |
RV1 | Rotavirus Vaccine, monovalent (Rotarix®) (formerly called ROTA) | |
Td | Tetanus & diphtheria Vaccine, adult/adolescent formulation | |
ViCPS | Vi Capsular Polysaccharide (Inactivated Typhoid) Vaccine | |
DCVRN | Developing Country Vaccine Regulators' Network | |
AVAREF | African Vaccine Regulatory Forum | |
HDCV | Human Diploid Cell Vaccine | |
QIV | Quadrivalent Influenza Vaccine | |
LAIV | Live attenuated influenza vaccine | |
PPSV | pneumococcal polysaccharides vaccine | |
PCV | Pneumococcal Conjugate Vaccine | |
PCV | Pneumococcal conjugate vaccine | |
PPV | Pneumococcal Polysaccharide Vaccine | |
7vPCV | seven valent pneumococcal conjugate vaccine | |
23vPPV | 23 valent pneumococcal polysaccharide vaccine | |
23vPPV | 23 valent pneumococcal polysaccharide vaccine | |
LAIV | Live attenuated influenza vaccine | |
VPGs | Vaccine Purchasing Groups | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
MVI | Malaria Vaccine Initiative | |
LAIV | Live Attenuated Influenza Vaccine | |
ATIV | Adjuvanted Trivalent Inactivated Vaccine | |
ATIV | Adjuvanted Trivalent Inactivated Vaccine | |
AVIP | Anthrax Vaccine Immunization Program | |
HVTN | HIV Vaccine Trials Network | |
IAVI | International AIDS Vaccine Initiative | |
IAVI | International AIDS Vaccine Initiative | |
LAIV | Live Attenuated Influenza Vaccine | |
TFVC | Texans For Vaccine Choice | |
NCVIA | National Childhood Vaccine Injury Act | |
LAIV4 | Live, Attenuated Intranasal Vaccine Quadrivalent | |
LAIV4 | Live, Attenuated Intranasal Vaccine Quadrivalent | |
IPV | Intra Polio Vaccine | |
TIV PFS | Trivalent Influenza Vaccine ; Pre-Filled Syringe | |
Gam-COVID-Vac | Gamaleya Coronavirus Disease Vaccine | |
Gam-COVID-Vac | Gamaleya Coronavirus Disease Vaccine | |
CORV | Coronavirus Vaccine | |
CORV | Coronavirus Vaccine | |
BBIBP-CorV | Beijing Bio-Institute of Biological Products Coronavirus Vaccine | |
BBIBP-CorV | Beijing Bio-Institute of Biological Products Coronavirus Vaccine | |
BBIBP-CorV | Beijing Bio-Institute of Biological Products Coronavirus Vaccine | |
BBIBP-CorV | Beijing Bio-Institute of Biological Products Coronavirus Vaccine | |
COVAC | Coronavirus Vaccine | |
COVAC | Coronavirus Vaccine | |
COVAC1 | Coronavirus Vaccine 1 | |
COVAC1 | Coronavirus Vaccine 1 | |
COVAX | COVID-19 Vaccine | |
COVAX | COVID-19 Vaccine | |
COVAX-19 | COVID-19 Vaccine | |
COVAX-19 | COVID-19 Vaccine | |
V-SAFE | Vaccine Safety Assessment For Essential workers | |
V-SAFE | Vaccine Safety Assessment For Essential workers | |
V-SAFE | Vaccine Safety Assessment For Essential workers | |
VIPIT | Vaccine-Induced Prothrombotic Immune Thrombocytopenia | |
VIPIT | Vaccine-Induced Prothrombotic Immune Thrombocytopenia | |
VITT | Vaccine-induced Immune Thrombotic Thrombocytopenia | |
VITT | Vaccine-induced Immune Thrombotic Thrombocytopenia | |
GFVF | Google Flu Vaccine Finder | |
NCOVAX | nCov Vaccine | |
NCOVAX | nCov Vaccine | |
NCVP | nCoV Vaccine program | |
NCVP | nCoV Vaccine program | |
mRNA | Messenger Ribonucleic Acid (Vaccine for treating nCoV) | |
mRNA | Messenger Ribonucleic Acid (Vaccine for treating nCoV) | |
BNT | Pfizer BioNTech COVID-19 vaccine | |
VE | Vaccine Effectiveness -- Used in Latest CDC reports on CoViD vaccines. | |
NCVA | National Childhood Vaccine Injury Act | |
PVBL | Portal of Vaccine Based Lists | |
FV | Flow Vaccine | |
ELSAV | Ethical, Legal and Social Aspects of Vaccine Research and Vaccination Policies in Europe (EU project) | |
ELSAV | Ethical, Legal and Social Aspects of Vaccine Research and Vaccination Policies in Europe (EU project) | |
ELSAV | Ethical, Legal and Social Aspects of Vaccine Research and Vaccination Policies in Europe (EU project) | |
ELSAV | Ethical, Legal and Social Aspects of Vaccine Research and Vaccination Policies in Europe (EU project) | |
VRK | Vaccine Related Kinase | |
VSD | Vaccine Safety Datalink | |
VSD | Vaccine Safety Datalink | |
ABV | Anything But Vaccine | |
IVAC | International Vaccine Access Center | |
IVAC | International Vaccine Access Center |
What does vaccine mean?
- vaccine, vaccinum(noun)
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies
Still can't find the acronym definition you were looking for? Use our Power Search technology to look for more unique definitions from across the web!
Citation
Use the citation options below to add these abbreviations to your bibliography.
Style:MLAChicagoAPA
"vaccine." Abbreviations.com. STANDS4 LLC, 2024. Web. 25 Apr. 2024. <https://www.abbreviations.com/vaccine>.
Discuss these vaccine abbreviations with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In